Exosomes in Autoimmunity: Mediators of Autoantigen Presentation and Targets for Therapeutic Intervention in Autoimmune Diseases
Authors:
- Hailah M. AlmohaimeedHAHailah M. Almohaimeed
- Amany I. AlmarsAAAmany I. Almars
- Wajnat A. TounsiWTWajnat A. Tounsi
- Zuhair M. MohammedsalehZMZuhair M. Mohammedsaleh
- Rajashree PanigrahiRPRajashree Panigrahi
- Indu SinghISIndu Singh
- Surbhi SinghSSSurbhi Singh
- Bikram DharaBDBikram Dhara
- Daniel Ejim UtiDUDaniel Ejim Uti
Open Access
- 28 November 2025
- journal article
- review article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 46 (1)
Abstract
Exosomes, as integral mediators of cellular communication, have emerged as crucial players in the pathogenesis and potential treatment of autoimmune diseases. This review explores the dual role of exosomes in mediating autoantigen presentation and their impact on immune dysregulation. Exosomes, by virtue of their cargo—comprising proteins, peptides, and nucleic acids—can influence immune tolerance, potentially leading to the breakdown of self-tolerance and the perpetuation of autoimmune responses. They carry and present autoantigens directly to T cells or indirectly via antigen-presenting cells, thereby initiating and sustaining immune reactions characteristic of autoimmune disorders. Furthermore, the review delves into the therapeutic implications of targeting exosomal pathways, discussing strategies such as inhibiting exosome biogenesis, modifying exosomal content, and blocking exosome uptake by immune cells. Such interventions present promising avenues for developing novel treatments aimed at mitigating autoimmune responses. By harnessing the unique properties of exosomes, future research may pave the way for innovative therapeutic strategies that offer more precise and personalized treatment options for patients suffering from autoimmune diseases. Graphical AbstractKeywords
This publication has 128 references indexed in Scilit:
- STAT3 Signaling Pathway in Health and DiseaseMedcomm, 2025
- Exosomes in Autoimmune Diseases: A Review of Mechanisms and Diagnostic ApplicationsClinical Reviews in Allergy & Immunology, 2025
- The interaction of innate immune and adaptive immune systemMedcomm, 2024
- Engineering exosomes to reshape the immune microenvironment in breast cancer: Molecular insights and therapeutic opportunitiesClinical and Translational Medicine, 2024
- Potential of Nano-Engineered Stem Cells in the Treatment of Multiple Sclerosis: A Comprehensive ReviewCellular and Molecular Neurobiology, 2023
- Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunitiesMedcomm, 2022
- The contribution of thymic tolerance to central nervous system autoimmunitySeminars in Immunopathology, 2020
- The functional role of surface molecules on extracellular vesicles in cancer, autoimmune diseases, and coagulopathyJournal of Leukocyte Biology, 2020
- MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to BedsideTargeted Oncology, 2020
- The role of extracellular vesicles when innate meets adaptiveSeminars in Immunopathology, 2018